Use of prophylactic antifungals in the immunocompromised host.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics

• Publication date

  2007-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.TRIPLEO.2006.11.003PMID 17379157
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prophylactic treatment with miconazole in patients highly predisposed to fungal infection. A placebo-controlled double-blind study.

  2009cited by this paper
• Pharmacological advances in the treatment of invasive candidiasis

  2006cited by this paper
• Predictive value of oral colonization by Candida yeasts for the onset of a nosocomial infection in elderly hospitalized patients.

  2006cited by this paper
• Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.

  2006cited by this paper
• Candida glabrata PDR1, a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite Mutants

  2006cited by this paper
• Fungal infections.

  2006cited by this paper
• Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.

  2005cited by this paper
• Enhanced clearance of Candida albicans from the oral cavities of mice following oral administration of Lactobacillus acidophilus

  2005cited by this paper
• A 2-year study of Candida-associated denture stomatitis treatment in aged care subjects.

  2005cited by this paper
• A randomized study of the use of fluconazole in continuous versus episodic therapy in patients with advanced HIV infection and a history of oropharyngeal candidiasis: AIDS Clinical Trials Group Study 323/Mycoses Study Group Study 40.

  2005cited by this paper
• Improved oral hygiene and Candida species colonization level in geriatric patients.

  2005cited by this paper
• Candidiasis (oropharyngeal).

  2005cited by this paper
• In Vitro Method To Study Antifungal Perfusion in Candida Biofilms

  2005cited by this paper
• Strategies for managing systemic fungal infection and the place of itraconazole.

  2005cited by this paper
• Cytotoxic drugs, radiotherapy and oral candidiasis.

  2004cited by this paper
• Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancer.

  2004cited by this paper
• Comparison of Antifungal Susceptibilities to Fluconazole and Voriconazole of Oral Candida glabrata Isolates from Head and Neck Radiation Patients

  2004cited by this paper
• Candidemia in patients with diabetes mellitus: epidemiology and predictors of mortality

  2004cited by this paper
• Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.

  2004cited by this paper
• Radiotherapy-induced salivary dysfunction.

  2004cited by this paper
• Salivary nystatin concentrations after administration of an osmotic controlled release tablet and a pastille

  2004cited by this paper
• Geographic Variation in the Susceptibilities of Invasive Isolates of Candida glabrata to Seven Systemically Active Antifungal Agents: a Global Assessment from the ARTEMIS Antifungal Surveillance Program Conducted in 2001 and 2002

  2004cited by this paper
• Interventions for preventing oral candidiasis for patients with cancer receiving treatment.

  2004cited by this paper
• Drug interactions in dentistry: the importance of knowing your CYPs.

  2004cited by this paper
• Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida.

  2004cited by this paper
• Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy

  2004cited by this paper
• Immunopathogenesis of Oropharyngeal Candidiasis in Human Immunodeficiency Virus Infection

  2004cited by this paper
• Xerostomia and hypofunction of the salivary glands in cancer therapy

  2003cited by this paper
• Decreased excretion of antimicrobial proteins and peptides in saliva of patients with oral candidiasis.

  2003cited by this paper
• Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial

  2003cited by this paper
• Global Distribution and Outcomes for Candida Species Causing Invasive Candidiasis: Results from an International Randomized Double-Blind Study of Caspofungin Versus Amphotericin B for the Treatment of Invasive Candidiasis

  2003cited by this paper
• Prevention and treatment of the consequences of head and neck radiotherapy.

  2003cited by this paper
• Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis

  2003cited by this paper
• Oral sequelae of head and neck radiotherapy.

  2003cited by this paper
• Oral manifestations in HIV infection: fungal and bacterial infections, Kaposi's sarcoma

  2003cited by this paper
• A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand.

  2002cited by this paper
• Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever.

  2002cited by this paper
• Saliva--the defender of the oral cavity.

  2002cited by this paper
• Differences in risk factors among clinical types of oral candidiasis in the Women's Interagency HIV Study.

  2002cited by this paper
• High Oral Prevalence of Candida krusei in Leprosy Patients in Northern Thailand

  2002cited by this paper
• Efficacy, tolerability and development of resistance in HIV-positive patients treated with fluconazole for secondary prevention of oropharyngeal candidiasis: a randomized, double-blind, placebo-controlled trial.

  2002cited by this paper
• In Vivo Pathogenicity of Eight Medically Relevant Candida Species in an Animal Model

  2002cited by this paper
• A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.

  2001cited by this paper
• Antimicrobial Peptides: Properties and Applicability

  2001cited by this paper
• Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression.

  2001cited by this paper
• Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome

  2001cited by this paper
• A randomized, double‐blind, placebo‐controlled study of itraconazole capsules for the prevention of deep fungal infections in immunodeficient patients with HIV infection

  2001cited by this paper
• The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species

  2001cited by this paper
• Insulin-dependent diabetes mellitus and oral soft tissue pathologies: II. Prevalence and characteristics of Candida and Candidal lesions.

  2000cited by this paper
• Oral candidosis.

  2000cited by this paper
• Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

  2000cited by this paper
• Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

  2000cited by this paper
• Prevention of oral mucositis or oral candidiasis for patients with cancer receiving chemotherapy (excluding head and neck cancer).

  2000cited by this paper
• A double-blind, randomized, placebo-controlled trial of itraconazole capsules as antifungal prophylaxis for neutropenic patients.

  2000cited by this paper
• The epidemiology of non-albicans Candida in oropharyngeal candidiasis in HIV patients.

  2000cited by this paper
• Refractory mucosal candidiasis in advanced human immunodeficiency virus infection.

  2000cited by this paper
• Epidemiology of Oropharyngeal CandidaColonization and Infection in Patients Receiving Radiation for Head and Neck Cancer

  1999cited by this paper
• Med Pediatr Oncol

  1999cited by this paper
• A RANDOMISED, DOUBLE‐BLIND STUDY OF ITRACONAZOLE VERSUS PLACEBO IN THE TREATMENT AND PREVENTION OF ORAL OR OESOPHAGEAL CANDIDOSIS IN PATIENTS WITH HIV INFECTION

  1999cited by this paper
• Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto.

  1999cited by this paper
• Oral health and microflora in an institutionalised elderly population in Canada.

  1999cited by this paper
• Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.

  1999cited by this paper
• Factors associated with the presence of denture related stomatitis in complete denture wearers: a preliminary investigation.

  1998cited by this paper
• A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistance.

  1998cited by this paper
• Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents.

  1998cited by this paper
• Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.

  1998cited by this paper
• Clinical evaluation and microbiology of oropharyngeal infection due to fluconazole-resistant Candida in human immunodeficiency virus-infected patients.

  1998cited by this paper
• Weekly Fluconazole for the Prevention of Mucosal Candidiasis in Women with HIV Infection

  1997cited by this paper
• Weekly fluconazole for preventing mucosal candidiasis in HIV infection [4] (multiple letters)

  1997cited by this paper
• The Cost-Effectiveness of Fluconazole Prophylaxis against Primary Systemic Fungal Infections in AIDS Patients

  1997cited by this paper
• The association of yeasts and denture stomatitis with behavioral and biologic factors.

  1997cited by this paper
• The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010

  1997cited by this paper
• Selection and pathogenicity of Candida albicans in HIV infection.

  1997cited by this paper
• Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.

  1997cited by this paper
• Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.

  1996cited by this paper
• Prophylaxis with nystatin pastilles for HIV-associated oral candidiasis.

  1996cited by this paper
• Nystatin pastilles and suspension in the treatment of oral candidosis

  1996cited by this paper
• A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection

  1995cited by this paper
• Prospective study of fluconazole suspension for the treatment of oesophageal candidiasis in patients with AIDS

  1995cited by this paper
• A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.

  1995cited by this paper
• Comparison of fluconazole with oral polyenes in the prevention of fungal infections in neutropenic patients

  1995cited by this paper
• Fluconazole‐resistant candidosis in an HIV cohort

  1994cited by this paper
• Preventing Fungal Infection in Neutropenic Patients with Acute Leukemia: Fluconazole Compared with Oral Amphotericin B

  1994cited by this paper
• A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with hematological or oncological malignancies

  1994cited by this paper
• The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Bone Marrow Transplantation Team.

  1994cited by this paper
• Prevention of bacterial and fungal infections in acute leukemia patients: a new and potent combination of oral norfloxacin and amphotericin B.

  1993cited by this paper
• Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV‐infected patients: A double‐blind placebo‐controlled study

  1993cited by this paper
• Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group.

  1993cited by this paper
• Fluconazole Prophylaxis of Fungal Infections in Patients with Acute Leukemia: Results of a Randomized Placebo-Controlled, Double-Blind, Multicenter Trial

  1993cited by this paper
• Oral ketoconazole prophylaxis for Candida infections during induction therapy for acute leukaemia in adults: more bacteraemias

  1992cited by this paper
• Comparative trial of oral clotrimazole and nystatin for oropharyngeal candidiasis prophylaxis in orthotopic liver transplant patients.

  1992cited by this paper
• A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.

  1992cited by this paper
• Efficacy of chlorhexidine and nystatin rinses in prevention of oral complications in leukemia and bone marrow transplantation.

  1992cited by this paper
• Samaranayake lp, wright twmf. Oral candidosis, london, butterworth & co ltd

  1992cited by this paper
• Host factors associated with HIV-related oral candidiasis. A review.

  1992cited by this paper
• A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukaemia.

  1991cited by this paper
• Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients

  1991cited by this paper
• Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily.

  1991cited by this paper
• Effect of selective elimination of the oral flora on mucositis in irradiated head and neck cancer patients

  1991cited by this paper
• Prophylaxis of candidiasis in cancer patients.

  1990cited by this paper

• Considerations of Nystatin Roll in Oral Candidiasis Scenario and the COVID-19 Pandemic—A Review

  2023cites this paper
• Probiotics as a prophylaxis to prevent oral candidiasis in patients with Sjogren's syndrome: a double-blinded, placebo-controlled, randomized trial

  2020cites this paper
• Biopharmaceutical profile of a clotrimazole nanoemulsion: Evaluation on skin and mucosae as anticandidal agent

  2019cites this paper
• Oral Colonization of Malassezia species

  2018cites this paper
• ORAL HAIRY LEUKOPLAKIA: a case report and a review of literature

  2017cites this paper
• Oral Candidiasis and the Medically Compromised Patient

  2016cites this paper
• Current strategies for prevention of oral manifestations of human immunodeficiency virus.

  2016cites this paper
• Self-nanoemulsifying drug delivery system (SNEDDS) with enhanced solubilization of nystatin for treatment of oral candidiasis: Design, optimization, in vitro and in vivo evaluation

  2016cites this paper
• Oral candidiasis in the newborn and infant

  2015cites this paper
• Development of alginate microspheres as nystatin carriers for oral mucosa drug delivery.

  2015cites this paper
• Candidiasis oral en el recién nacido y el lactante

  2015cites this paper
• Report on World Workshops on Oral Medicine (WWOM) IV and V: research themes and citation impact: WWOM VI steering committee.

  2015cites this paper
• Clinical presentation and risk factors of osteoradionecrosis

  2015cites this paper
• Oral mucosal diseases: evaluation and management.

  2014cites this paper
• Oral Candidiasis - A Review. -

  2014cites this paper
• 54 – Iatrogenic disease

  2013cites this paper
• Sjögren’s Syndrome in Older Patients

  2013cites this paper
• Evaluation of antimicrobial activity and cell viability of Aloe vera sponges

  2013cites this paper
• Review of the complications associated with treatment of oropharyngeal cancer: a guide for the dental practitioner.

  2013cites this paper
• Oral candidosis in lichen planus: the diagnostic approach is of major therapeutic importance

  2012cites this paper
• Oral candidiasis – A review

  2012cites this paper
• Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: ultrastructural effects and release studies.

  2012cites this paper
• Nanoemulsiones de nistatina para el tratamiento de candidiasis muco-cutáneas

  2012cites this paper
• In vitro antifungal susceptibility of Candida spp. oral isolates from HIV-positive patients and control individuals.

  2011cites this paper
• In vitro antifungal susceptibility of Candida spp . oral isolates from HIV-positive patients and control individuals

  2011cites this paper
• Risk factors for oral candidiasis in Brazilian HIV-infected adult patients

  2010cites this paper
• Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination

  2010cites this paper
• A new topical treatment protocol for oral hairy leukoplakia.

  2010cites this paper
• Antifungal drug resistance of oral fungi

  2010cites this paper
• Tratamento tópico da leucoplasia pilosa bucal e desenvolvimento e validação de um instrumento para avaliação do conhecimento de cirurgiões dentistas sobre HIV/AIDS

  2009cites this paper
• Efflux-Mediated Antifungal Drug Resistance

  2009influential citation
• Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents.

  2009cites this paper
• Periodontal conditions, oral Candida albicans and salivary proteins in type 2 diabetic subjects with emphasis on gender

  2009cites this paper
• In vitro antimicrobial activity of medicinal plants against oral Candida albicans isolates

  2009cites this paper
• R R R Resposta im esposta im esposta im esposta im esposta imune a doenças une a doenças une a doenças une a doenças une a doenças

  2009cites this paper
• Treatment strategies for oropharyngeal candidiasis

  2009influential citation
• Management of oral infections in cancer patients.

  2008cites this paper
• The Oral Cavity and Lips

  2008cites this paper
• Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.

  2008cites this paper
• Oral Manifestations of Sjögren’s Syndrome

  2008cites this paper
• Oral healthcare for HIV-infected patients: an international perspective

  2008influential citation
• Mucosal lesions in older adults.

  2007cites this paper
• Oropharyngeal candidiasis in HIV infection in Tanzania

  2005cites this paper